# Trade Mark Journal No.2026/019 8 May 2026

## WO0000001914213 (9,35,44)

Office of origin: Switzerland

Date of International Registration:26 January 2026
Date of designation in the UK: 26 January 2026

International priority date claimed: 28 July 2025 (Switzerland) (837795)

Class 9
  Computer hardware; computer software; software and software applications; computer hardware and software for downloading, storing and synchronizing data (text and image files) in databases; computer software and computer applications for measuring, recording, monitoring and evaluating data related to patients' physical health; computer software and computer applications for evaluating pharmacogenomic data using individual genomic profiles of humans or animals; computer software and computer applications for creating and managing electronic patient records; software applications in the field of personalized medicine; software applications for visual representation of medical analyses concerning the interactions between chemical substances, medical substances and pharmaceutical products in relation to the human and animal body.
Class 35
  Updating and management of medical data, particularly in connection with medicines, food supplements, prescriptions, dosages and patient records in computer databases; computerized management of medical records and files.
Class 44
  Advice with respect to health; health care; medical and veterinary care, advice and therapy services; medical services intended for medical (physical) condition monitoring, maintaining and improvement; advice in the field of personalized medicine; medical services in the field of personalized medicine; medical and veterinary services for monitoring, evaluating and improving drug treatments and drug therapies; performing medical analyses and providing medical interpretation (diagnosis) of medical analyses concerning the interactions between chemical substances, medical substances and pharmaceutical products in relation to the human and animal body.

MedGenie AG

Representative: PRINS Intellectual Property AG, Postfach 1739, CH-8027 Zürich, SWITZERLAND